ログイン

Nucleic acid 1.1

Nucleic acid 1.1
100問 • 1年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    Responsible for the biochemical complexity created by splice variants obtained by hnRNA

    Transcriptome

  • 2

    The base sequence in a mRNA determines the amino acid sequence for the protein synthesized

    Genetic code.

  • 3

    The base sequence of an mRNA molecule involves only 4 different bases - A, C, G, andU (T/F)

    True.

  • 4

    A three-nucleotide sequence in an mRNA molecule that codes for a specifi c amino acid

    Codon

  • 5

    Based on all possible combination of bases A, G, C, U‖ there are 64 possible codes

    Codon

  • 6

    The assignment of the 64 mRNA codons to specific amino acids (or stop signals)

    Genetic code.

  • 7

    Choose the following those genetic code is highly degenerate .

    Many amino acids are designated by more than one codon, Met and Trp, Arg, Leu, and Ser, synonyms

  • 8

    Codons that specify the same amino acid are called

    Synonym

  • 9

    - have only a single codon

    Met and Trp

  • 10

    represented by two codons

    Amino acids

  • 11

    - represented by six codons. –

    Arg, Leu, and Ser

  • 12

    All synonyms for an amino acid fall within a single box in unless there are more than four synonyms

    Pattern and arrangements of genetic code.

  • 13

    The significance of the ―single box pattern - the first two bases are the same

    Arrangement of genetic code table.

  • 14

    With minor exceptions the code is the same in all organisms

    Genetic code almost universal.

  • 15

    The same codon specifies the same amino acid whether the cell is a bacterial cell, a corn plant cell, or a human cell

    Genetic code almost universal

  • 16

    What isnthe start codon.

    AUG

  • 17

    What is the stop codon

    UAG, UAA, UGA

  • 18

    a three-nucleotide sequence on a tRNA molecule that is complementary to a codon on an mRNA

    Anticodon.

  • 19

    During protein synthesis amino acids do not directly interact with the codons of an mRNA molecule (T/F)

    True.

  • 20

    tRNA molecules as intermediaries deliver amino acids to mRNA (T/F)

    True.

  • 21

    process in which mRNA codons are deciphered to synthesize a protein molecule

    Translation

  • 22

    an rRNA–protein complex - serves as the site of protein synthesis:

    Ribosome

  • 23

    is a RNA catalyst The mRNA binds to the small subunit of the ribosome

    Ribosomes.

  • 24

    A ribosome active site

    Large subunits.

  • 25

    addition of specific amino acids to the 3’-OH group of tRNA.

    Activation of tRNA

  • 26

    Begins with binding of mRNA to small ribosomal subunit such that its first codon (initiating codon AUG) occupies a site called the P site (peptidyl site)

    Initiation of protein synthesis.

  • 27

    Adjacent to the P site in an mRNA–ribosome complex is A site (aminoacyl site) and the next tRNA with the appropriate anticodon binds to it.

    Elongation.

  • 28

    the part of translation in which a ribosome moves down an mRNA molecule three base positions (one codon) so that a new codon can occupy the ribosomal A site

    Translocation.

  • 29

    The polypeptide continues to grow via translocation until all necessary amino acids are in place and bonded to each other

    Termination.

  • 30

    No tRNA has an anticodon that can base pair with these stop codons. (T/F)

    True.

  • 31

    The polypeptide is then cleaved from the tRNA through hydrolysis

    Protein release factor.

  • 32

    gives the protein the final form it needs to be fully functional

    Post translational processing

  • 33

    a complex of mRNA and several ribosomes

    Polysome (polyribosome)

  • 34

    several ribosomes bind to a single mRNA - polysomes (T/F)

    True.

  • 35

    An error in base sequence reproduced during DNA replication

    Mutation.

  • 36

    Errors in genetic information is passed on during transcription.

    Mutation.

  • 37

    The altered information can cause changes in amino acid sequence during protein synthesis and thereby alter protein function

    Mutation.

  • 38

    Unwanted changes in DNA sequence lead to diease and disjunction

    Mutation.

  • 39

    What are the five step of translation process

    Activation of tRNA, initiation of protein synthesis, Elongation, Termination, Post translation process

  • 40

    2 types of common mutation

    Point of mutation, Frameshift mutation

  • 41

    both mRNA codons code for the same amino acid

    Point mutation

  • 42

    The point mutation has produced a codon that codes for a different amino acid

    Point mutation

  • 43

    has produced a stop codon, resulting in termination of protein synthesis

    point mutation

  • 44

    is a mutation that inserts or deletes a base in a DNA molecule base sequence.

    Frameshift mutation

  • 45

    Mutation are caused by?

    Mutagen

  • 46

    substance or agent that causes a change in the structure of a gene:

    Mutagen

  • 47

    Two important types of mutagens

    Radiation, Chemical agent

  • 48

    mutagenic that can possibly cause cancers

    Ultraviolet, Xray, Radioactivity, Cosmic radiation

  • 49

    Tiny disease causing agents with outer protein envelope and inner nucleic acid core

    Viruses

  • 50

    They can not reproduce outside their host cells (living organisms)

    Viruses

  • 51

    Invade their host cells to reproduce and in the process disrupt the normal cell’s operation

    Viruses

  • 52

    Many human diseases are of viral origin, e. g. Common cold, smallpox, rabies, influenza, hepatitis, andAIDS

    Viruses

  • 53

    Antibodies produced against inactive viral or bacterial envelopes will kill the active bacteria and viruses

    Vaccines.

  • 54

    inactive virus or bacterial envelope

    Vaccines.

  • 55

    The study of biochemical techniques that allow the transfer of a foreign gene to a host organism and produce the protein associated with the added gene

    Biotechnology

  • 56

    Bacterial strains such as E. coli inserted with circular plasmids, and/or yeast cells carrying vectors containing foreign genes are used for this purpose

    Biotechnology

  • 57

    Plasmids (double stranded DNA) replicate independently in bacteria or yeast.

    Biotechnology

  • 58

    E. coli cells of a specific strain containing the plasmid of interest are treated with chemicals to dissolve their membranes and release the cellular contents

    Dissolution of cells

  • 59

    The cellular contents are fractionated to obtain plasmids

    Isolation of plasmid fraction

  • 60

    Restriction enzymes are used to cleave the double-stranded DNA

    Cleavage of plasmid DNA

  • 61

    Using the same restriction enzyme the gene of interest is removed from a chromosome of another organism

    Gene removal from another organism:

  • 62

    The gene (from Step 4) and the opened plasmid (from Step 3) are mixed in the presence of the enzyme DNA ligase to splice them together.

    Gene–plasmid splicing

  • 63

    The recombinant DNA prepared in stept 5 are transferred to a live E. coli culture where they can be replicated, trasncribed and translated.

    Uptake of recombinant DNA:

  • 64

    Transformed cell can reproduce a large number of identical cells

    Clones

  • 65

    are the cells that have descended from a single cell and have identical DNA

    Clones

  • 66

    Each clone can synthesize the protein directed by foreign gene it carries (T/F)

    True.

  • 67

    is a method for rapidly producing multiple copies of a DNA nucleotide sequence (gene).

    PRC

  • 68

    PRC means?

    Polymerase chain reaction

  • 69

    What are the requirements of PRC

    Source of gene to be copied, Thermostable DNA polymerase, Source of heat

  • 70

    What are the requirements of PRC

    Thermostable plastic container, Set of two oligonucleotides with complementary sequence to the gene (primers), Deoxynucleotide triphosphates (dATP, dGTP, dCTP and dTTP)

  • 71

    This method allows to produce billions of copies of a specific gene in a few hours

    Polymerase chain reaction

  • 72

    Also known as “DOWN SYNDROME”

    Trisomy 21

  • 73

    Has triplicate copy of the 21st chromosome

    Trisomy 21

  • 74

    What are the symptoms and manifestation of trisomy 21

    Sterility, impaired cognitive abilities, distinct physical features

  • 75

    Trisomy X also know as

    Triple X syndrome, Super Female Syndrome

  • 76

    What are the symptoms of trisomy X

    Low IQ, Delayed speech, ADHD, Abdominal pain, Delayed motor development

  • 77

    Males with this condition usually have underdeveloped male secondary sexual characteristics and they usually have more feminine features.

    Klinefelter syndrome

  • 78

    KLINEFELTER SYNDROME also know as

    XXY syndrome

  • 79

    klinefelter's syndrome symptoms are

    Lower IQ than sibs, Tall stature, Poor muscle tone, Reduce secondary sexual characteristics, Gynecomastia, Small testes/ Infertility

  • 80

    It runs antiparallel/opposite direction

    DNA

  • 81

    What is the sugar in RNA

    Ribose

  • 82

    What is the sugar in DNA

    Deoxyribose.

  • 83

    What is the base in RNA

    Adenine, Guanine, Cytosine, Uracil

  • 84

    What is the base in DNA

    Adenine, Guanine, Cytosine, Thymine

  • 85

    What is the purpose of RNA

    Expression, Central dogma

  • 86

    What is the purpose of DNA

    Storage, Genetic

  • 87

    What is the form in RNA

    Single bond

  • 88

    What is the form in DNA

    Double bond

  • 89

    What is the synthesis of RNA

    Transcription

  • 90

    What is the synthesis in DNA

    Replication

  • 91

    Dna to Rna is?

    Transcription

  • 92

    What sugar ?

    Ribose.

  • 93

    ?

    Aglycosidic bond.

  • 94

    What type of base is present

    Purine.

  • 95

    ?

    Phosphoester bond

  • 96

    ?

    Phosphoanhydrase bond.

  • 97

    It facilitate the phosphorylation

    Kinase (Transfer)

  • 98

    PO4 + PO4

    Phosphoa hydrase bond

  • 99

    Sugar + PO4

    Phospoester bond

  • 100

    Sugar + Base

    Glycosidic bond

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    3回閲覧 • 66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious disease.

    Infectious disease.

    Quinn Karylle Fuentes · 65問 · 2年前

    Infectious disease.

    Infectious disease.

    65問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 2年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 2年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 2年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 2年前

    Introduction.

    Introduction.

    17問 • 2年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 2年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 2年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 2年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 2年前

    Carbohydrates

    Carbohydrates

    75問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 2年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 2年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 2年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 2年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 2年前

    INTRODUCTION

    INTRODUCTION

    98問 • 2年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 2年前

    lab (1-2)

    lab (1-2)

    15問 • 2年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 2年前

    lab 1-2

    lab 1-2

    14問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 2年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 2年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 2年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 2年前

    Unit 3.

    Unit 3.

    39問 • 2年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 2年前

    Histamin and kinins

    Histamin and kinins

    70問 • 2年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 2年前

    PUD.

    PUD.

    45問 • 2年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 2年前

    ..

    ..

    61問 • 2年前
    Quinn Karylle Fuentes

    Lipids.

    Lipids.

    Quinn Karylle Fuentes · 67問 · 2年前

    Lipids.

    Lipids.

    67問 • 2年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 2年前

    lipids.

    lipids.

    71問 • 2年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 2年前

    LAB ✨

    LAB ✨

    93問 • 2年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 2年前

    Drug discovery.

    Drug discovery.

    87問 • 2年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 2年前

    disease of lipids.

    disease of lipids.

    13問 • 2年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 2年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 2年前

    Carbohydrates

    Carbohydrates

    98問 • 2年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 2年前

    Dynamic.

    Dynamic.

    96問 • 2年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 2年前

    Unit 1

    Unit 1

    32問 • 2年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    Responsible for the biochemical complexity created by splice variants obtained by hnRNA

    Transcriptome

  • 2

    The base sequence in a mRNA determines the amino acid sequence for the protein synthesized

    Genetic code.

  • 3

    The base sequence of an mRNA molecule involves only 4 different bases - A, C, G, andU (T/F)

    True.

  • 4

    A three-nucleotide sequence in an mRNA molecule that codes for a specifi c amino acid

    Codon

  • 5

    Based on all possible combination of bases A, G, C, U‖ there are 64 possible codes

    Codon

  • 6

    The assignment of the 64 mRNA codons to specific amino acids (or stop signals)

    Genetic code.

  • 7

    Choose the following those genetic code is highly degenerate .

    Many amino acids are designated by more than one codon, Met and Trp, Arg, Leu, and Ser, synonyms

  • 8

    Codons that specify the same amino acid are called

    Synonym

  • 9

    - have only a single codon

    Met and Trp

  • 10

    represented by two codons

    Amino acids

  • 11

    - represented by six codons. –

    Arg, Leu, and Ser

  • 12

    All synonyms for an amino acid fall within a single box in unless there are more than four synonyms

    Pattern and arrangements of genetic code.

  • 13

    The significance of the ―single box pattern - the first two bases are the same

    Arrangement of genetic code table.

  • 14

    With minor exceptions the code is the same in all organisms

    Genetic code almost universal.

  • 15

    The same codon specifies the same amino acid whether the cell is a bacterial cell, a corn plant cell, or a human cell

    Genetic code almost universal

  • 16

    What isnthe start codon.

    AUG

  • 17

    What is the stop codon

    UAG, UAA, UGA

  • 18

    a three-nucleotide sequence on a tRNA molecule that is complementary to a codon on an mRNA

    Anticodon.

  • 19

    During protein synthesis amino acids do not directly interact with the codons of an mRNA molecule (T/F)

    True.

  • 20

    tRNA molecules as intermediaries deliver amino acids to mRNA (T/F)

    True.

  • 21

    process in which mRNA codons are deciphered to synthesize a protein molecule

    Translation

  • 22

    an rRNA–protein complex - serves as the site of protein synthesis:

    Ribosome

  • 23

    is a RNA catalyst The mRNA binds to the small subunit of the ribosome

    Ribosomes.

  • 24

    A ribosome active site

    Large subunits.

  • 25

    addition of specific amino acids to the 3’-OH group of tRNA.

    Activation of tRNA

  • 26

    Begins with binding of mRNA to small ribosomal subunit such that its first codon (initiating codon AUG) occupies a site called the P site (peptidyl site)

    Initiation of protein synthesis.

  • 27

    Adjacent to the P site in an mRNA–ribosome complex is A site (aminoacyl site) and the next tRNA with the appropriate anticodon binds to it.

    Elongation.

  • 28

    the part of translation in which a ribosome moves down an mRNA molecule three base positions (one codon) so that a new codon can occupy the ribosomal A site

    Translocation.

  • 29

    The polypeptide continues to grow via translocation until all necessary amino acids are in place and bonded to each other

    Termination.

  • 30

    No tRNA has an anticodon that can base pair with these stop codons. (T/F)

    True.

  • 31

    The polypeptide is then cleaved from the tRNA through hydrolysis

    Protein release factor.

  • 32

    gives the protein the final form it needs to be fully functional

    Post translational processing

  • 33

    a complex of mRNA and several ribosomes

    Polysome (polyribosome)

  • 34

    several ribosomes bind to a single mRNA - polysomes (T/F)

    True.

  • 35

    An error in base sequence reproduced during DNA replication

    Mutation.

  • 36

    Errors in genetic information is passed on during transcription.

    Mutation.

  • 37

    The altered information can cause changes in amino acid sequence during protein synthesis and thereby alter protein function

    Mutation.

  • 38

    Unwanted changes in DNA sequence lead to diease and disjunction

    Mutation.

  • 39

    What are the five step of translation process

    Activation of tRNA, initiation of protein synthesis, Elongation, Termination, Post translation process

  • 40

    2 types of common mutation

    Point of mutation, Frameshift mutation

  • 41

    both mRNA codons code for the same amino acid

    Point mutation

  • 42

    The point mutation has produced a codon that codes for a different amino acid

    Point mutation

  • 43

    has produced a stop codon, resulting in termination of protein synthesis

    point mutation

  • 44

    is a mutation that inserts or deletes a base in a DNA molecule base sequence.

    Frameshift mutation

  • 45

    Mutation are caused by?

    Mutagen

  • 46

    substance or agent that causes a change in the structure of a gene:

    Mutagen

  • 47

    Two important types of mutagens

    Radiation, Chemical agent

  • 48

    mutagenic that can possibly cause cancers

    Ultraviolet, Xray, Radioactivity, Cosmic radiation

  • 49

    Tiny disease causing agents with outer protein envelope and inner nucleic acid core

    Viruses

  • 50

    They can not reproduce outside their host cells (living organisms)

    Viruses

  • 51

    Invade their host cells to reproduce and in the process disrupt the normal cell’s operation

    Viruses

  • 52

    Many human diseases are of viral origin, e. g. Common cold, smallpox, rabies, influenza, hepatitis, andAIDS

    Viruses

  • 53

    Antibodies produced against inactive viral or bacterial envelopes will kill the active bacteria and viruses

    Vaccines.

  • 54

    inactive virus or bacterial envelope

    Vaccines.

  • 55

    The study of biochemical techniques that allow the transfer of a foreign gene to a host organism and produce the protein associated with the added gene

    Biotechnology

  • 56

    Bacterial strains such as E. coli inserted with circular plasmids, and/or yeast cells carrying vectors containing foreign genes are used for this purpose

    Biotechnology

  • 57

    Plasmids (double stranded DNA) replicate independently in bacteria or yeast.

    Biotechnology

  • 58

    E. coli cells of a specific strain containing the plasmid of interest are treated with chemicals to dissolve their membranes and release the cellular contents

    Dissolution of cells

  • 59

    The cellular contents are fractionated to obtain plasmids

    Isolation of plasmid fraction

  • 60

    Restriction enzymes are used to cleave the double-stranded DNA

    Cleavage of plasmid DNA

  • 61

    Using the same restriction enzyme the gene of interest is removed from a chromosome of another organism

    Gene removal from another organism:

  • 62

    The gene (from Step 4) and the opened plasmid (from Step 3) are mixed in the presence of the enzyme DNA ligase to splice them together.

    Gene–plasmid splicing

  • 63

    The recombinant DNA prepared in stept 5 are transferred to a live E. coli culture where they can be replicated, trasncribed and translated.

    Uptake of recombinant DNA:

  • 64

    Transformed cell can reproduce a large number of identical cells

    Clones

  • 65

    are the cells that have descended from a single cell and have identical DNA

    Clones

  • 66

    Each clone can synthesize the protein directed by foreign gene it carries (T/F)

    True.

  • 67

    is a method for rapidly producing multiple copies of a DNA nucleotide sequence (gene).

    PRC

  • 68

    PRC means?

    Polymerase chain reaction

  • 69

    What are the requirements of PRC

    Source of gene to be copied, Thermostable DNA polymerase, Source of heat

  • 70

    What are the requirements of PRC

    Thermostable plastic container, Set of two oligonucleotides with complementary sequence to the gene (primers), Deoxynucleotide triphosphates (dATP, dGTP, dCTP and dTTP)

  • 71

    This method allows to produce billions of copies of a specific gene in a few hours

    Polymerase chain reaction

  • 72

    Also known as “DOWN SYNDROME”

    Trisomy 21

  • 73

    Has triplicate copy of the 21st chromosome

    Trisomy 21

  • 74

    What are the symptoms and manifestation of trisomy 21

    Sterility, impaired cognitive abilities, distinct physical features

  • 75

    Trisomy X also know as

    Triple X syndrome, Super Female Syndrome

  • 76

    What are the symptoms of trisomy X

    Low IQ, Delayed speech, ADHD, Abdominal pain, Delayed motor development

  • 77

    Males with this condition usually have underdeveloped male secondary sexual characteristics and they usually have more feminine features.

    Klinefelter syndrome

  • 78

    KLINEFELTER SYNDROME also know as

    XXY syndrome

  • 79

    klinefelter's syndrome symptoms are

    Lower IQ than sibs, Tall stature, Poor muscle tone, Reduce secondary sexual characteristics, Gynecomastia, Small testes/ Infertility

  • 80

    It runs antiparallel/opposite direction

    DNA

  • 81

    What is the sugar in RNA

    Ribose

  • 82

    What is the sugar in DNA

    Deoxyribose.

  • 83

    What is the base in RNA

    Adenine, Guanine, Cytosine, Uracil

  • 84

    What is the base in DNA

    Adenine, Guanine, Cytosine, Thymine

  • 85

    What is the purpose of RNA

    Expression, Central dogma

  • 86

    What is the purpose of DNA

    Storage, Genetic

  • 87

    What is the form in RNA

    Single bond

  • 88

    What is the form in DNA

    Double bond

  • 89

    What is the synthesis of RNA

    Transcription

  • 90

    What is the synthesis in DNA

    Replication

  • 91

    Dna to Rna is?

    Transcription

  • 92

    What sugar ?

    Ribose.

  • 93

    ?

    Aglycosidic bond.

  • 94

    What type of base is present

    Purine.

  • 95

    ?

    Phosphoester bond

  • 96

    ?

    Phosphoanhydrase bond.

  • 97

    It facilitate the phosphorylation

    Kinase (Transfer)

  • 98

    PO4 + PO4

    Phosphoa hydrase bond

  • 99

    Sugar + PO4

    Phospoester bond

  • 100

    Sugar + Base

    Glycosidic bond